These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8164154)

  • 21. Immunohistochemical evaluation of uveal melanocytic tumors. Expression of HMB-45, S-100 protein, and neuron-specific enolase.
    Burnier MN; McLean IW; Gamel JW
    Cancer; 1991 Aug; 68(4):809-14. PubMed ID: 1855181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic utility of combining PRAME and HMB-45 stains in primary melanocytic tumors.
    Rasic D; Korsgaard N; Marcussen N; Precht Jensen EM
    Ann Diagn Pathol; 2023 Dec; 67():152211. PubMed ID: 37717457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of immunohistochemical labelling of melanocyte differentiation antibodies melan-A, tyrosinase and HMB 45 with NKIC3 and S100 protein in the evaluation of benign naevi and malignant melanoma.
    Orchard GE
    Histochem J; 2000 Aug; 32(8):475-81. PubMed ID: 11095072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical distinction of epithelioid histiocytic proliferations from epithelioid melanocytic nevi.
    Busam KJ; Granter SR; Iversen K; Jungbluth AA
    Am J Dermatopathol; 2000 Jun; 22(3):237-41. PubMed ID: 10871066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of HMB-45 immunoreactivity in common and cellular blue nevi.
    Wood WS; Tron VA
    J Cutan Pathol; 1991 Aug; 18(4):261-3. PubMed ID: 1939785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Desmoplastic (sclerotic) nevus: an underrecognized entity that resembles dermatofibroma and desmoplastic melanoma.
    Harris GR; Shea CR; Horenstein MG; Reed JA; Burchette JL; Prieto VG
    Am J Surg Pathol; 1999 Jul; 23(7):786-94. PubMed ID: 10403301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical expression of cyclooxygenase-2 (COX-2) in oral nevi and melanoma.
    de Souza do Nascimento J; Carlos R; Delgado-Azañero W; Mosqueda Taylor A; de Almeida OP; Romañach MJ; de Andrade BA
    J Oral Pathol Med; 2016 Jul; 45(6):440-3. PubMed ID: 26608958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HMB-45 antibody reactivity in pigmented lesions of the conjunctiva.
    Glasgow BJ; McCall LC; Foos RY
    Am J Ophthalmol; 1990 Jun; 109(6):696-700. PubMed ID: 2189315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Morphological changes in melanocytic nevi induced by exogenous factors].
    Tronnier M; Alexander M; Neitmann M; Brinckmann J; Wolff HH
    Hautarzt; 2000 Aug; 51(8):561-6. PubMed ID: 10997310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amelanotic blue nevus: a variant of blue nevus.
    Bhawan J; Cao SL
    Am J Dermatopathol; 1999 Jun; 21(3):225-8. PubMed ID: 10380042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The initial steps of tumor progression in melanocytic lineage: a histochemical approach.
    Wollina U; Kilian U; Henkel U; Schaarschmidt H; Knopf B
    Anticancer Res; 1991; 11(4):1405-14. PubMed ID: 1746897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoperoxidase technique modified by counterstain with azure B as a diagnostic aid in evaluating heavily pigmented melanocytic neoplasms.
    Kamino H; Tam ST
    J Cutan Pathol; 1991 Dec; 18(6):436-9. PubMed ID: 1723081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recognition of malignant melanoma by monoclonal antibody HMB-45. An immunohistochemical study of 200 paraffin-embedded cutaneous tumors.
    Wick MR; Swanson PE; Rocamora A
    J Cutan Pathol; 1988 Aug; 15(4):201-7. PubMed ID: 3053811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of melanocytic differentiation markers in malignant melanomas of the oral and sinonasal mucosa.
    Prasad ML; Jungbluth AA; Iversen K; Huvos AG; Busam KJ
    Am J Surg Pathol; 2001 Jun; 25(6):782-7. PubMed ID: 11395556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
    Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
    Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of immunohistochemical staining of the novel antibody melan-A with S100 protein and HMB-45 in malignant melanoma and melanoma variants.
    Blessing K; Sanders DS; Grant JJ
    Histopathology; 1998 Feb; 32(2):139-46. PubMed ID: 9543670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human monoclonal antibodies that distinguish cutaneous malignant melanomas from benign nevi in fixed tissue sections.
    Imam A; Mitchell MS; Modlin RL; Taylor CR; Kempf RA; Kan-Mitchell J
    J Invest Dermatol; 1986 Feb; 86(2):145-8. PubMed ID: 3528308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrent pigmented melanocytic nevus. A benign lesion, not to be mistaken for malignant melanoma.
    Sexton M; Sexton CW
    Arch Pathol Lab Med; 1991 Feb; 115(2):122-6. PubMed ID: 1992976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Melanocytic activation in HIV-1 disease: HMB-45 staining in common acquired nevi. Military Medical Consortium for the Advancement of Retroviral Research.
    Smith KJ; Skelton HG; Heimer W; Baxter D; Angritt P; Frisman D; Wagner KF
    J Am Acad Dermatol; 1993 Oct; 29(4):539-44. PubMed ID: 7691905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignant melanoma with paradoxical maturation.
    Ruhoy SM; Prieto VG; Eliason SL; Grichnik JM; Burchette JL; Shea CR
    Am J Surg Pathol; 2000 Dec; 24(12):1600-14. PubMed ID: 11117780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.